Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
F13A1 encodes the coagulation factor XIII A subunit. Zusätzlich bieten wir Ihnen Coagulation Factor XIII, A1 Polypeptide Kits (36) und Coagulation Factor XIII, A1 Polypeptide Proteine (12) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 329 products:
Human Polyclonal F13A1 Primary Antibody für ELISA, WB - ABIN408658
Higaki, Nakano, Onaka, Amano, Tanioka, Harada, Hashimoto, Sakaida, Okita: Clinical significance of measuring blood coagulation factor XIIIA regularly and continuously in patients with Crohn's disease. in Journal of gastroenterology and hepatology 2006
Human Polyclonal F13A1 Primary Antibody für ID, ELISA - ABIN2473585
Wang, Yang, Ran: Localized papular mucinosis with IgA nephropathy: a case report. in Archives of dermatology 2011
Human Monoclonal F13A1 Primary Antibody für FACS, IF - ABIN5577652
Davie, Fujikawa, Kisiel: The coagulation cascade: initiation, maintenance, and regulation. in Biochemistry 1991
kinetic and structural analysis of interactions between thrombin (zeige F2 Antikörper) and the Factor XIII (zeige UGDH Antikörper) activation peptide
These findings provide insight into assembly of the fibrinogen/FXIII-A2B2 complex in both physiologic and therapeutic situations.
FXIIIa exhibits a preference for Q237 in crosslinking reactions within fibrinogen alphaC (233-425) followed by Q328 and Q366.
factor XIII (zeige UGDH Antikörper) Val34Leu polymorphism is associated with coronary artery diseases risk, especially myocardial infarction. Age and sex did not affect the relationship between factor XIII (zeige UGDH Antikörper) Val34Leu polymorphism and diseases risk (Meta-Analysis)
Genetic basis of severe factor XIII (zeige UGDH Antikörper) deficiency in a large cohort of Indian patients has been uncovered.
Mutations in the activation peptide of full-length recombinant FXIII regulate activation rates by thrombin (zeige F2 Antikörper), and V34L influences in vivo thrombus formation by increased cross-linking of the clot (zeige TXNDC17 Antikörper).
Report immunochromatographic test for detection of anti-factor XIII (zeige UGDH Antikörper) A subunit antibodies that can diagnose 90 % of cases with autoimmune haemorrhaphilia XIII (zeige UGDH Antikörper).
there is an evidence for association between factor XIII (zeige UGDH Antikörper) Val34Leu polymorphism and CSX (zeige NKX2-5 Antikörper)
These findings expose a newly recognized, essential role for fibrin crosslinking during whole blood clot (zeige TXNDC17 Antikörper) formation and consolidation and establish FXIIIa activity as a key determinant of thrombus composition and size.
Results show that FXIII-B Arg95 variant is associated with an increased risk of abdominal aortic aneurysms (AAA (zeige APP Antikörper)) suggesting a possible role for FXIII in AAA (zeige APP Antikörper) pathogenesis.
Mast cells have the ability to produce and degrade FXIIIA depending on their chymase (zeige CMA1 Antikörper) expression profile: mast cells expressing chymase (zeige CMA1 Antikörper) degrade FXIIIA, whereas mast cells that do not express chymase (zeige CMA1 Antikörper) mainly produce FXIIIA
A lack of factor XIII (zeige UGDH Antikörper) leads to prolonged clotting times, increased signs of inflammation, and elevated bacterial dissemination in streptococcal skin diseases.
5-HT (zeige DDC Antikörper) inhibits Factor XIII (zeige UGDH Antikörper)-A-mediated plasma fibronectin (zeige FN1 Antikörper) matrix assembly and crosslinking in osteoblast cultures via direct competition with transamidation
High Transglutaminase factor XIII (zeige UGDH Antikörper) promotes arthritis through mechanisms linked to inflammation and bone erosion.
Fibrinogen from mice harboring the Fibgamma390-396A mutation exhibited reduced binding to FXIII, and plasma from these mice exhibited delayed FXIII activation and fibrin crosslinking, indicating these residues mediate FXIII binding and activation.
FXIII-A serves as a preadipocyte-bound proliferation/differentiation switch that mediates effects of hepatocyte-produced circulating pFN.
Physiological significance of mouse TG2 (zeige TGM2 Antikörper) and Factor XIII (zeige UGDH Antikörper) through identification of substrate proteins in MC3T3-E1 cells.
Studies indicate that in FXIII-A-knockout mice, tail-tip bleeding times are doubled and clot (zeige TXNDC17 Antikörper) stability, assessed by thromboelastography, was impaired compared with wild-type mice.
This gene encodes the coagulation factor XIII A subunit. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as plasma carrier molecules. Platelet factor XIII is comprised only of 2 A subunits, which are identical to those of plasma origin. Upon cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. It also crosslinks alpha-2-plasmin inhibitor, or fibronectin, to the alpha chains of fibrin. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits\; and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion.
coagulation factor XIII, A1 polypeptide
, blood coagulation factor XIII A1 subunit
, coagulation factor XIII A1 subunit
, coagulation factor XIII A chain
, Coagulation factor XIII A chain
, coagulation factor XIII A chain-like
, FSF, A subunit
, bA525O21.1 (coagulation factor XIII, A1 polypeptide)
, coagulation factor XIII, A polypeptide
, coagulation factor XIIIa
, factor XIIIa
, fibrin stabilizing factor, A subunit
, protein-glutamine gamma-glutamyltransferase A chain
, transglutaminase A chain
, transglutaminase. plasma
, coagulation factor XIII, A1 subunit
, coagulation factor XIIIA
, Factor XIIIA
, coagulation factor XIII, alpha subunit